Microdosing GLP1 in Menopause & Perimenopause What it is : Microdosing GLP-1 in menopause and perimenopause means using a lower, personalized dose of GLP-1 medication to gently support appetite control, energy, and focus
Ozempic can cause dizziness through dehydration from gastrointestinal side effects (nausea, vomiting, diarrhoea), reduced fluid and caloric intake due to appetite suppression, blood pressure changes (especially with concurrent antihypertensive medications), and hypoglycaemia when combined with insulin or sulfonylureas
- Despus de abierto utilizar inmediatamente el vial completo.
It may affect any part of the oral mucosa, but most frequently the gingiva, where it is usually bilaterally symmetrical, does not transgress the mucogingival junction, and does not involve the marginal gingiv (Figure 1) [4, 6]